These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32850691)

  • 21. A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.
    Jiang W; Shen Y; Ding Y; Ye C; Zheng Y; Zhao P; Liu L; Tong Z; Zhou L; Sun S; Zhang X; Teng L; Timko MP; Fan L; Fang W
    Int J Cancer; 2018 Jan; 142(2):357-368. PubMed ID: 28921531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
    Chai R; Zhao Y; Su Z; Liang W
    Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CancerSiamese: one-shot learning for predicting primary and metastatic tumor types unseen during model training.
    Mostavi M; Chiu YC; Chen Y; Huang Y
    BMC Bioinformatics; 2021 May; 22(1):244. PubMed ID: 33980137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue of origin detection for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph convolutional neural networks.
    Nguyen TH; Doan NNT; Tran TH; Huynh LAK; Doan PL; Nguyen THH; Nguyen VTC; Nguyen GTH; Nguyen HN; Giang H; Tran LS; Phan MD
    J Transl Med; 2024 Jul; 22(1):618. PubMed ID: 38961476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
    Jiang Y; He J; Wang X; Liu C; Zhou W; Liu D; Guo Z; Liu K
    Platelets; 2023 Dec; 34(1):2212071. PubMed ID: 37212262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting cancer origins with a DNA methylation-based deep neural network model.
    Zheng C; Xu R
    PLoS One; 2020; 15(5):e0226461. PubMed ID: 32384093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature.
    Li D; Yang W; Zhang Y; Yang JY; Guan R; Xu D; Yang MQ
    BMC Med Genomics; 2018 Nov; 11(Suppl 5):106. PubMed ID: 30453959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Cancer Tissue-of-Origin by a Machine Learning Method Using DNA Somatic Mutation Data.
    Liu X; Li L; Peng L; Wang B; Lang J; Lu Q; Zhang X; Sun Y; Tian G; Zhang H; Zhou L
    Front Genet; 2020; 11():674. PubMed ID: 32760423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network-based drug sensitivity prediction.
    Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
    Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
    ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convolutional neural network models for cancer type prediction based on gene expression.
    Mostavi M; Chiu YC; Huang Y; Chen Y
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):44. PubMed ID: 32241303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of RNA-Seq and microarray in the prediction of protein expression and survival prediction.
    Kim WJ; Choi BR; Noh JJ; Lee YY; Kim TJ; Lee JW; Kim BG; Choi CH
    Front Genet; 2024; 15():1342021. PubMed ID: 38463169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    Huang S; Hu P; Lakowski TM
    BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the functional alteration signatures across different cancer types with support vector machine and feature analysis.
    Wang S; Cai Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2218-2227. PubMed ID: 29277326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel.
    Sun M; Xu B; Chen C; Zhu Y; Li X; Chen K
    Clin Epigenetics; 2024 Feb; 16(1):25. PubMed ID: 38336771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images.
    Liu Y; Lawson BC; Huang X; Broom BM; Weinstein JN
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concordance Study of a 520-Gene Next-Generation Sequencing-Based Genomic Profiling Assay of Tissue and Plasma Samples.
    Wang M; Chen X; Dai Y; Wu D; Liu F; Yang Z; Song B; Xie L; Yang L; Zhao W; Zhang C; Shen W; Fan C; Teng C; Zhao X; Gao N; Shang D; Zhao G; Xin T
    Mol Diagn Ther; 2022 May; 26(3):309-322. PubMed ID: 35305253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.